作者:
Hervé,Avet-Loiseau [1]
;
Nizar J,Bahlis [2]
;
Wee-Joo,Chng [3]
;
Tamas,Masszi [4]
;
Luisa,Viterbo [5]
;
Ludek,Pour [6]
;
Peter,Ganly [7]
;
Antonio,Palumbo [8]
;
Michele,Cavo [9]
;
Christian,Langer [10]
;
Andrzej,Pluta [11]
;
Arnon,Nagler [12]
;
Shaji,Kumar [13]
;
Dina,Ben-Yehuda [14]
;
S Vincent,Rajkumar [15]
;
Jesus,San-Miguel [14]
;
Deborah,Berg [16]
;
Jianchang,Lin [17]
;
Helgi,van de Velde [17]
;
Dixie-Lee,Esseltine [17]
;
Alessandra,di Bacco [17]
;
Philippe,Moreau [17]
;
Paul G,Richardson [18]
作者单位:
Laboratory for Genomics in Myeloma, University Cancer Center of Toulouse Institut National de la Santé, Toulouse, France.
[1]
Southern Alberta Cancer Research Institute, University of Calgary, Calgary, AB, Canada.
[2]
Department of Hematology-Oncology, National University Cancer Institute, Singapore.
[3]
St. István, St. László Hospital, Budapest, Hungary.
[4]
3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
[5]
Instituto Português de Oncologia do Porto Francisco Gentil, Entidade Pública Empresarial (IPOPFG, EPE), Porto, Portugal.
[6]
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
[7]
Department of Haematology, Christchurch Hospital, Christchurch, New Zealand.
[8]
Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria (AOU) S. Giovanni Battista, Torino, Italy.
[9]
"Seràgnoli" Institute of Hematology, University of Bologna, Bologna, Italy.
[10]
Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
[11]
Department of Hematological Oncology, Oncology Specialist Hospital, Brzozow, Poland.
[12]
Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
[13]
Mayo Clinic, Rochester, MN.
[14]
Hadassah Medical Center, Kiryat Hadassah, Jerusalem, Israel.
[15]
Clínica Universidad de Navarra, Centro Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.
[16]
Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA.
[17]
Hematology Department, University Hospital Hôtel Dieu, Nantes, France; and.
[18]
Dana-Farber Cancer Institute, Boston, MA.
[19]
DOI
10.1182/blood-2017-06-791228
PMID
29054911
发布时间
2021-02-02